SCHEMBL403776

SCHEMBL403776

C#CC#C[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149572 0.97
SCHEMBL234746 0.76
SCHEMBL5916128 0.72
SCHEMBL9626668 0.69
SCHEMBL18191283 0.65 CACNA2D1 (0.35)
SCHEMBL432931 0.65
SCHEMBL9224764 0.64
SCHEMBL9511007 0.64
SCHEMBL11910718 0.63
SCHEMBL4699 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0552637-B1 Method of manufacturing a polyacetylene conjugate polymer MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 1998-11-25 EP claimed
CN-117098757-A GPR84 antagonists and uses thereof 里米诺生物科学有限公司 2023-11-21 CN disclosed
CN-107001295-B Isoxazole hydroxamic acid compounds as LpxC inhibitors 诺华股份有限公司 2021-02-02 CN disclosed
EP-3233843-B1 ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LPXC INHIBITORS NOVARTIS AG (CH) 2019-10-16 EP disclosed
US-20190031676-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-01-31 US disclosed
EP-3114126-B1 1,2-DIHYDRO-3H-PYRROLO[1,2-C]IMIDAZOL-3-ONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS IDORSIA PHARMACEUTICALS LTD (CH) 2018-10-31 EP disclosed
US-10106544-B2 1,2-dihydro-3H-pyrrolo[1,2-C]imidazol-3-one derivatives and their use as antibacterial agents IDORSIA PHARMACEUTICALS LTD (CH) 2018-10-23 US disclosed
US-10029994-B2 Isoxazole hydroxamic acid compounds as LpxC inhibitors NOVARTIS AG (CH) 2018-07-24 US disclosed
EP-3344617-A1 PAN-GENOMIC INHIBITORS OF NS5A PROTEIN ENCODED BY HCV, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR INHIBITOR SYNTHESIS, AND THEIR SYNTHESIS AND APPLICATION METHODS. Ivachtchenko, Alexandre Vasilievich (US) 2018-07-11 EP disclosed
EP-3341378-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2018-07-04 EP disclosed
EP-1329455-A1 Metal carbene complexes, methods and intermediates for making them and their use in metathesis reactions UNIVERSITEIT GENT (BE) 2003-07-23 EP disclosed
US-20030087306-A1 Methods for identifying novel multimeric agents that modulate receptors THERAVANCE BIOPHARMA R&D IP, LLC 2003-05-08 US disclosed
EP-1082289-A1 METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS Advanced Medicine, Inc. (US) 2001-03-14 EP disclosed
EP-1082289-A4 METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS ADVANCED MEDICINE INC (US) 2001-03-14 EP disclosed
WO-1999066944-A9 METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS ADVANCED MEDICINE INC (US) 2000-07-27 WO disclosed
WO-1999066944-A1 METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS ADVANCED MEDICINE, INC. (US) 1999-12-29 WO disclosed
EP-0552637-B1 Method of manufacturing a polyacetylene conjugate polymer MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 1998-11-25 EP disclosed
WO-1997038802-A9 POLYMERIC SELF-ASSEMBLED MONO- AND MULTILAYERS AND THEIR USE IN PHOTOLITHOGRAPHY 1997-12-11 WO disclosed
WO-1997038802-A1 POLYMERIC SELF-ASSEMBLED MONO- AND MULTILAYERS AND THEIR USE IN PHOTOLITHOGRAPHY THE TEXAS A & M UNIVERSITY SYSTEM (US) 1997-10-23 WO disclosed
US-5091488-A POLYETHYLACETYLENE DERIVATIVE AND PROCESS FOR PREPARATION THEREOF DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1992-02-25 US disclosed